This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Biopharma industry is always evolving. However, thought leaders in the Biopharma industry offer innovative insights and strategic direction. You're on the right page to find these experts; we’ll discuss Biopharma's top 12 thought leaders, highlighting their unique expertise and what they can teach you. Let’s dive in.
In 2023, Planview was pleased to sponsor several WHY Summit Events: Basil, Switzerland, and Philadelphia. R evisit WHY Summit 2023 in this blog What is WHY Summit The WHY Summit brings together project, program, and portfolio management professionals from the pharmaceutical and healthcare industries.
As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% However, the pharma/biopharma industry overall shows stagnant R&D activity. growth from 2023 to 2024. increase from 2022. Total R&D expenditure is approximately $276.81
As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% However, the pharma/biopharma industry shows overall stagnant R&D activity. growth from 2023 to 2024. What is driving transformation in the pharma industry? increase from 2022.
The sponsorship agreement, which begins this year, will continue through 2023 and beyond. Over the past 20 years, alliances have shown the power of collaboration. Alliance managers have become masters of high-stakes collaboration. ASAP and its members have led this success.
April 25, 2023 – Frost & Sullivan researched the contract research organizations industry and, based on its analysis results, recognizes Emmes with the 2023 Global Competitive Strategy Leadership Award. years, to become a truly global company with a diverse mix of public sector and biopharma clients. SAN ANTONIO, TX.
The sponsorship agreement, which begins this year, will continue through 2023 and beyond. Over the past 20 years, alliances have shown the power of collaboration. Alliance managers have become masters of high-stakes collaboration. ASAP and its members have led this success.
Collaborations with academic institutions and clinical research centers will further drive innovation and expand market opportunities. Competitive Intensity Strategic alliances and proprietary technologies are becoming essential for market leadership. The Proteomics Ecosystem: Whos Driving Innovation?
While 2024 saw a 41% decline in aggregate deal value , falling from $222 billion in 2023 to $130 billion, 2025 is poised for a rebound. Cross-Industry Collaborations Enabling Advanced Research Technological innovation and implementation, especially in AI-driven drug discovery and adaptive clinical trials , was a focal point of the conference.
We organize all of the trending information in your field so you don't have to. Join 61,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content